July 2020

Let’s start with a number that should give any pharmaceutical executive pause: $2 billion. That’s the estimated cost to bring […]

1. Introduction: Defining the Landscape of Off-Label Use and Drug Repurposing The pharmaceutical sector is continuously seeking innovative avenues to